COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome

A number of pneumonia cases of unknown causes have emerged in Wuhan, Hubei, China since December 2019.1 After sequencing analysis of samples from the lower respiratory tract, a coronavirus,2 which was last named as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).3 On February 11, 2020, the World Health Organization (WHO) announced a new name for the disease caused by 2019-nCoV: coronavirus disease 2019 (COVID-19).4 With the arrival of the Spring Festival, an epidemic SARS-CoV-2 infection has spread rapidly.

Source: Journal of Infection - May 27, 2020 Category: Infectious Diseases Authors: Jianhua Hu, Xiaoli Zhang, Xuan Zhang, Hong Zhao, Jiangshan Lian, Shaorui Hao, Hongyu Jia, Meifang Yang, Yingfeng Lu, Dairong Xiang, Huan Cai, Shanyan Zhang, Jueqing Gu, Chanyuan Ye, Guodong Yu, Ciliang Jin, Lin Zheng, Yida Yang, Jifang Sheng Tags: Letter to the Editor Source Type: research